Nabi and GlaxoSmithKline to Develop Anti-Smoking Vaccine

Nabi Biopharmaceuticals is partnering with GlaxoSmithKline to develop an anti-smoking vaccine. Na...  More »

Nabi Biopharmaceuticals is partnering with GlaxoSmithKline to develop an anti-smoking vaccine. Nabi is developing NicVAX, a vaccine whose intent it is to train the immune system to produce antibodies that attach themselves to nicotine.  « Less